NeuTec Pharma Ltd (NTP:LN)
was acquired by NOVN:VX
NeuTec Pharma plc is a biopharmaceutical company which develops and manufactures genetically recombinant antibodies. The Group identifies and replicates antibodies produced from patients who have previously recovered from bacterial and fungal infections. Their products are structured towards life threatening infections.